- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07625566
Anodal tDCS Over Left PPC Enhances Visuospatial Attention and Alpha Power Among Young Adults
Background: Visuospatial attention enables individuals to detect and process relevant stimuli efficiently. The posterior parietal cortex (PPC), a core hub of the dorsal attention network, exerts top-down control over visual scanning and is closely linked to alpha-band oscillations (8-13 Hz), which index attentional allocation and inhibition of distractors. Transcranial direct current stimulation (tDCS) offers a noninvasive method to alter cortical excitability transiently, but evidence for its effects on PPC-mediated attention and alpha power remains mixed.
Objective: This randomized, single-blind trial examined whether anodal tDCS over the left PPC modulates visuospatial attention and resting-state alpha power in young adults, and whether EEG changes predict behavioral performance.
Method: Thirty-two healthy participants (18-40 years) were randomized to anodal (2 mA, 20 min; n=15) or sham (n=17) stimulation. Cancellation Test performance and resting-state EEG were assessed pre- and post-stimulation. EEG analyses focused on artifact-free alpha power; regression models probed associations between neural and behavioral changes.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
İ̇stanbul
-
Beykoz, İ̇stanbul, Turkije (Türkiye), 34820
- Istanbul Medipol University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Age between 18 and 40 years
- Score of 21 or higher on the Montreal Cognitive Assessment Scale (MoCA)
Exclusion Criteria:
- History of neurological or psychiatric illness
- Uncorrected visual impairments
- MoCA score of 21 or lower
- Use of medications affecting cortical excitability
- History of seizures or epilepsy
- Presence of intracranial metal objects, implanted stimulating devices, or pacemakers
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Anodal tDCS Group
|
Anodal tDCS Protocol: In the Anodal tDCS participant group, a direct current of 2 mA was applied for 20 minutes in accordance with the safety guidelines.
To provide cortical stimulation, the superficial anodal electrode of the device was placed on the P3 region (left PPC), which is located in the left superior parietal lobe, corresponds to Brodmann area (BA) 40, and is associated with the dorsal visual pathway according to the international 10-20 EEG system.
The reference electrode was placed on the contralateral (opposite) shoulder.
|
|
Sham-vergelijker: Sham tDCS Group
|
Sham tDCS Protocol: The anode superficial electrode of the device was placed on the P3 region (left PPC), located in the left superior parietal lobe, corresponding to Brodmann area (BA) 40, and associated with the dorsal visual pathway according to the international 10-20 EEG system.
The reference electrode was placed on the contralateral (opposite) shoulder.
In the Sham tDCS group, a single 20-minute sham session was administered over the left posterior parietal cortex (P3) without delivering current, in accordance with the safety guidelines.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
EEG recording and power in alpha band
Tijdsspanne: Before and immediately after applying tDCS
|
EEG recordings were acquired in a semi-dark, electrically shielded Faraday room using a BrainAmp 32-Channel DC System (Brain Products, Munich, Germany).
Signals were sampled at 500 Hz with a 0.01-250 Hz bandpass filter and recorded using BrainVision Recorder software.
A 32-channel Ag/AgCl electrode cap (Easycap) was positioned according to the international 10-20 system.
Resting-state EEG data were collected for 4 minutes with eyes open and 4 minutes with eyes closed.
Numerical evaluation of artifact-free EEG data for power density calculation is performed using Fast Fourier Transform (FFT) with 0.5 Hz frequency resolution, and alpha (8-13 Hz) bands were calculated and then averaged over these power spectrum values.
The amplitude values, measured from peak to peak, were recorded for each individual, and the necessary data for statistical analysis were collected.
|
Before and immediately after applying tDCS
|
|
Cancellation Test
Tijdsspanne: Before and immediately after applying tDCS
|
The Cancellation Test is one of the most widely used tools for assessing visuospatial attention.
IT consists of four subtests arranged on A4-sized sheets.
Each subtest includes 60 target stimuli distributed among 300 total stimuli.
For each subtest, separate scores are calculated for the right and left sides, including the number of correctly marked targets (IT1), omitted targets (IT2), incorrectly marked letters/shapes (IT3), total error score (IT4), and scanning time (IT5).
The total error score is calculated as the sum of omitted targets and incorrectly marked letters/shapes.
Achieving a high score (i.e., a high number of correctly marked targets and a low number of errors) and a short completion time (time score) indicate better performance.
İn the present study, the paper-and-pencil version of the Cancellation Test was chosen to reliably assess visuospatial attention and subtle tDCS-induced changes.
|
Before and immediately after applying tDCS
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Lütfü Hanoğlu, Professor, Medipol University
- Studie stoel: Mevhibe Sarıcaoğlu, PhD, Medipol University
- Studie directeur: Miray Budak, PhD, Rutgers University-Newark
- Studie stoel: Fatma Aydın, MsC, Medipol University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- E-10840098-772.02-605
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .